# Filing Detail

Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-21-008630
Filing Date
2021-07-12
Accepted
2021-07-09 18:30:34
Documents
22

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | filename1.htm | DRS/A | 2113060
2 | GRAPHIC | g105292g00q10.jpg | GRAPHIC | 132217
3 | GRAPHIC | g105292g01b28.jpg | GRAPHIC | 150161
4 | GRAPHIC | g105292g02i16.jpg | GRAPHIC | 138588
5 | GRAPHIC | g105292g03v00.jpg | GRAPHIC | 38952
6 | GRAPHIC | g105292g04e08.jpg | GRAPHIC | 102835
7 | GRAPHIC | g105292g06c15.jpg | GRAPHIC | 111049
8 | GRAPHIC | g105292g08e09.jpg | GRAPHIC | 94910
9 | GRAPHIC | g105292g11i11.jpg | GRAPHIC | 148998
10 | GRAPHIC | g105292g11x00.jpg | GRAPHIC | 131356
11 | GRAPHIC | g105292g14n52.jpg | GRAPHIC | 205903
12 | GRAPHIC | g105292g22i22.jpg | GRAPHIC | 149673
13 | GRAPHIC | g105292g22x23.jpg | GRAPHIC | 138465
14 | GRAPHIC | g105292g33i33.jpg | GRAPHIC | 100543
15 | GRAPHIC | g105292g37a01.jpg | GRAPHIC | 117136
16 | GRAPHIC | g105292g41a01.jpg | GRAPHIC | 68734
17 | GRAPHIC | g105292g41r43.jpg | GRAPHIC | 161504
18 | GRAPHIC | g105292g44i44.jpg | GRAPHIC | 103263
19 | GRAPHIC | g105292g57q01.jpg | GRAPHIC | 188778
20 | GRAPHIC | g105292g59q01.jpg | GRAPHIC | 188126
21 | GRAPHIC | g105292g61q01.jpg | GRAPHIC | 162880
22 | GRAPHIC | g105292g66i66.jpg | GRAPHIC | 56980
| Complete submission text file | 0000950123-21-008630.txt |  | 5716088

Mailing Address 23515 NE NOVELTY HILL RD., SUITE B221 #1 REDMOND WA 98077
Business Address 23515 NE NOVELTY HILL RD., SUITE B221 #1 REDMOND WA 98077 16502240857
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-04848 | Film No.: 211083882
SIC: 2834 Pharmaceutical Preparations